Trevena, Inc. (NASDAQ:TRVN – Get Free Report)’s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0120. Trevena shares last traded at $0.0120, with a volume of 194 shares traded.
Trevena Price Performance
The company has a market capitalization of $11,508.00, a price-to-earnings ratio of -0.00 and a beta of -0.55.
About Trevena
Trevena, Inc is a biopharmaceutical company focused on developing medicines that target G protein-coupled receptors (GPCRs), a class of proteins involved in pain, neurological conditions and other diseases. The company was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Trevena’s best-known product is OLINVYK (oliceridine) injection, an intravenous opioid analgesic approved by the U.S. Food and Drug Administration in 2020 for the management of acute pain severe enough to require an intravenous opioid analgesic in adults.
Featured Articles
- Five stocks we like better than Trevena
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
